The article delves into the intriguing potential of real-world evidence (RWE) to revolutionize the U.S. Food and Drug Administration’s (FDA) approval process for new drugs. By relying more on real-world data (RWD), regulatory decisions could become quicker, more economical, and maintain the current
The recent bankruptcy announcement of 23andMe, a leading direct-to-consumer genetic testing company, has spurred significant discussions about the security and privacy of genetic data. As the company navigates financial turmoil and operational challenges, concerns mount over the future of the
The healthcare sector faces dynamic shifts as we approach 2025, with significant implications for Human Resources (HR) management. In order to effectively respond, HR leaders must stay ahead of the curve by addressing key workforce trends, embracing technology, ensuring compliance, and fostering a
The introduction of the National Health (Privacy) Rules 2025 marks a significant shift in the privacy settings governing the handling of Medicare Benefits Schedule (MBS) and Pharmaceutical Benefits Schedule (PBS) claims information by Australian Government agencies. Taking effect on April 1, 2025,
In a groundbreaking initiative aimed at transforming the health regulatory landscape across the African continent, the first African Regulators Leadership Program (ARLP) was convened at the Wits Business School in Johannesburg. This program is designed to elevate the leadership skills and
The hospice industry faces significant regulatory challenges that have become more pronounced in recent years, with key concerns including evolving telehealth policies and program integrity issues. These challenges were highlighted by hospice professionals in the 2025 Outlook Survey conducted by
